DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Oxnard GR, Arcila ME, Sima CS.
Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.
Clin Cancer Res 2011;
17: 1616-1622
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.